Radiotherapy & Oncology
Volume 87, Issue 3 , Pages 357-360, June 2008

Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients

  • Maarten Vermaas

      Affiliations

    • Department of Surgical Oncology, andErasmus MC -- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • Joost J.M.E. Nuyttens

      Affiliations

    • Department of Radiotherapy, Erasmus MC – Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • Floris T.J. Ferenschild

      Affiliations

    • Department of Surgical Oncology, andErasmus MC -- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • Cornelis Verhoef

      Affiliations

    • Department of Surgical Oncology, andErasmus MC -- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • Alexander M.M. Eggermont

      Affiliations

    • Department of Surgical Oncology, andErasmus MC -- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • ,
  • Johannes H.W. de Wilt

      Affiliations

    • Department of Surgical Oncology, andErasmus MC -- Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Johannes H.W. de Wilt, Department of Surgical Oncology, Erasmus MC – Daniel den Hoed Cancer Centre, P.O. Box 5201, 3008 AE Rotterdam, The Netherlands.

Received 5 November 2007; received in revised form 21 February 2008; accepted 25 February 2008. published online 19 March 2008.

Abstract 

A total of 11 patients with recurrent rectal cancer who had been previously irradiated were treated with preoperative reirradiation (median dose 30Gy), surgery and IORT. This treatment was related with high morbidity, a short pain-free survival (5 months) and poor local control (27% after 3 years), although some patients have long-term distant control and survival.

Keywords: Rectal cancer, Recurrent, Radiotherapy, Reirradiation, Surgery, IORT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(08)00133-3

doi:10.1016/j.radonc.2008.02.021

Radiotherapy & Oncology
Volume 87, Issue 3 , Pages 357-360, June 2008